MAIA Biotechnology Receives FDA Clearance to Open U.S. Enrollment in Ongoing Phase 2 THIO-101 Trial Expansion
Additional data from THIO-101 trial expansion studies may further support a potential Accelerated Approval filing with FDA
Open original source